PT - JOURNAL ARTICLE AU - Matthew L. Robinson AU - Meklit Workneh AU - Sabine Dittrich AU - Spruha Kurlekar AU - Rebecca Yee AU - Maya C. Nirmalraj AU - Karen A. Robinson AU - Yukari C. Manabe TI - Host biomarkers to predict the severity of acute febrile illness: A scoping review AID - 10.1101/2019.12.21.19014753 DP - 2019 Jan 01 TA - medRxiv PG - 2019.12.21.19014753 4099 - http://medrxiv.org/content/early/2019/12/27/2019.12.21.19014753.short 4100 - http://medrxiv.org/content/early/2019/12/27/2019.12.21.19014753.full AB - Background Acute febrile illness (AFI) ranges from mild to mortal, yet severity is difficult to assess. Host biomarkers may identify patients with AFI who require a higher level of care; choosing appropriate biomarkers for this role among an expanding pool of candidates is challenging. We performed a scoping review to evaluate the performance of novel host biomarkers to predict AFI severity.Methods PubMed was systematically searched for manuscripts published January 1, 2013 to February 10, 2018 for studies reporting the association of host biomarker levels and a measure of disease severity among patients with a suspected or diagnosed cause of AFI. Identified abstracts and full text manuscripts were reviewed for eligibility by 2 reviewers. Biomarker performance was evaluated primarily by the area under the curve (AUC) of the receiver operator characteristic to distinguish severe disease. We aggregated data describing biomarker performance by AUC using weighted mean, fixed effects meta-analyses, and random effects meta-analyses.Results Among 2,303 manuscripts identified, 281 manuscripts met criteria for analysis. Data was extracted for 278 biomarkers evaluated in 45,737 participants. Among 89 biomarkers evaluated by ≥2 studies, there were 6 biomarkers (proadrenomedullin, copeptin, pro-atrial natriuretic peptide, serum triggering receptor expressed on myeloid cells-1, chitinase-3-like protein-1, and the pediatric sepsis biomarker risk model), that showed a weighted mean AUC >0.75 (range 0.75-0.84) in >500 patients over >2 studies.Conclusions Although several biomarkers show promise in predicting AFI severity across multiple studies, their test characteristics do not suggest that they may be used alone to determine AFI prognosis.Summary A systematic review and limited metanalysis of 89 host biomarkers revealed that most individual biomarkers offer modest performance in predicting the severity of acute febrile illness; several however have performance characteristics which have shown promise in multiple studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health [Grant UM1AI104681 for M. L. R] and FIND. FIND receives funding for improving AFI diagnostics from the Government of the United Kingdom; FIND was supported in this work by the Doctors Without Borders/Médecins Sans Frontières Febrile Illness Diagnostic Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData referenced in this manuscript is available in the supplementary materials.